Syndecan-1 in acute decompensated heart failure - Association with renal function and mortality -

Circulation Journal

Volumn 79, Issue 7, 2015, Pages 1511-1519

  de Oliveira Neves, Fernanda Macedo ^a   Meneses, Gdayllon Cavalcante ^a   Sousa, Nazareth Ermínia Araujo ^b   de Menezes, Ramon Róseo Paula Pessoa Bezerra ^a   Parahyba, Marcelo Coelho ^b   Martins, Alice Maria Costa ^a   Libório, Alexandre Braga ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Hospital Do Coração de Messejana   (Brazil)

Author keywords

Acute kidney injury; Endothelial function; Heart failure; Syndecan 1

Indexed keywords

BIOLOGICAL MARKER; SDC1 PROTEIN, HUMAN; SYNDECAN 1;

ACUTE DISEASE; ACUTE KIDNEY INJURY; AGED; BLOOD; BRAZIL; COMPLICATION; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; KIDNEY; MALE; METABOLISM; MIDDLE AGED; MORTALITY;

ACUTE DISEASE; ACUTE KIDNEY INJURY; AGED; BIOMARKERS; BRAZIL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; KIDNEY; MALE; MIDDLE AGED; SYNDECAN-1;

EID: 84934300963     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1195     Document Type: Article

References (43)

1. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population. Eur Heart J 2006; 27: 2725-2736.
2. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Day of admission and clinical outcomes for patients hospitalized for heart failure: Findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Circ Heart Fail 2008; 1: 50-57.
3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121: 948-954.
4. JCS Joint Working Group. Guidelines for treatment of acute heart failure (JCS 2011): Digest version. Circ J 2013; 77: 2157-2201.
5. Joffe SW, Webster K, McManus DD, Kiernan MS, Lessard D, Yarzebski J, et al. Improved survival after heart failure: A community-based perspective. J Am Heart Assoc 2013; 2: e000053, doi: 10.1161/JAHA.113.000053.
6. Shirakabe A, Hata N, Kobayashi N, Shinada T, Tomita K, Tsurumi M, et al. Prognostic impact of acute kidney injury in patients with acute decompensated heart failure. Circ J 2013; 77: 687-696.
7. Liotta M, Olsson D, Sartipy U, Holzmann MJ. Minimal changes in postoperative creatinine values and early and late mortality and cardiovascular events after coronary artery bypass grafting. Am J Cardiol 2014; 113: 70-75.
8. Moody WE, Edwards NC, Madhani M, Chue CD, Steeds RP, Ferro CJ, et al. Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: Cause or association? Atherosclerosis 2012; 223: 86-94.
9. Fliser D. Perspectives in renal disease progression: The endothelium as a treatment target in chronic kidney disease. J Nephrol 2010; 23: 369-376.
10. Elkayam U, Khan S, Mehboob A, Ahsan N. Impaired endotheliummediated vasodilation in heart failure: Clinical evidence and the potential for therapy. J Card Fail 2002; 8: 15-20.
11. Ganda A, Onat D, Demmer RT, Wan E, Vittorio TJ, Sabbah HN, et al. Venous congestion and endothelial cell activation in acute decompensated heart failure. Curr Heart Fail Rep 2010; 7: 66-74.
12. Savic-Radojevic A, Radovanovic S, Pekmezovic T, Pljesa-Ercegovac M, Simic D, Djukic T, et al. The role of serum VCAM-1 and TNF-α as predictors of mortality and morbidity in patients with chronic heart failure. J Clin Lab Anal 2013; 27: 105-112.
13. Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng 2012; 40: 840-848.
14. Curry FE, Adamson RH. Endothelial glycocalyx: Permeability barrier and mechanosensor. Ann Biomed Eng 2012; 40: 828-839.
15. Basile DP. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 2007; 72: 151-156.
16. Ostrowski SR, Pedersen SH, Jensen JS, Mogelvang R, Johansson PI. Acute myocardial infarction is associated with endothelial glycocalyx and cell damage and a parallel increase in circulating catecholamines. Crit Care 2013; 17: R32.
17. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation 1993; 88: 107-115.
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
19. Kellum JA, Lameire N; for the KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1). Crit Care 2013; 17: 204.
20. Verbrugge FH, Dupont M, Shao Z, Shrestha K, Singh D, Finucan M, et al. Novel urinary biomarkers in detecting acute kidney injury, persistent renal impairment, and all-cause mortality following decongestive therapy in acute decompensated heart failure. J Card Fail 2013; 19: 621-628.
21. Breidthardt T, Socrates T, Drexler B, Noveanu M, Heinisch C, Arenja N, et al. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care 2012; 16: R2.
22. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
23. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 2012; 60: 1455-1469.
24. Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, et al. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 2003; 5: 507-516.
25. Tsutamoto T, Hisanaga T, Fukai D, Wada A, Maeda Y, Maeda K, et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol 1995; 76: 803-808.
26. Tromp J, van der Pol A, Klip IJT, de Boer RA, Jaarsma T, van Glist WH, et al. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction. Circ Heart Fail 2014; 7: 457-462.
27. Wang JB, Zhang YJ, Zhang Y, Guan J, Chen LY, Fu CH, et al. Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetol 2013; 50: 111-115.
28. Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007; 116: 1896-1906.
29. Sallisalmi M, Tenhunen J, Yang R, Oksala N, Pettilä V. Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthe siol Scand 2012; 56: 316-322.
30. Grundmann S, Fink K, Rabadzhieva L, Bourgeois N, Schwab T, Moser M, et al. Perturbation of the endothelial glycocalyx in post cardiac arrest syndrome. Resuscitation 2012; 83: 715-720.
31. Jacob M, Saller T, Chappell D, Rehm M, Welsch U, Becker BF. Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability. Basic Res Cardiol 2013; 108: 347.
32. Constantinescu AA, Vink H, Spaan JA. Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arterioscler Thromb Vasc Biol 2003; 23: 1541-1547.
33. Dane MJ, Khairoun M, Lee DH, van den Berg BM, Eskens BJ, Boels MG, et al. Association of kidney function with changes in the endothelial surface layer. Clin J Am Soc Nephrol 2014; 9: 698-704.
34. Forman DE, Butler J, Wang Y, Abraham WT, O’Connor CM, Gottlieb SS, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67.
35. Vanmassenhove J, Vanholder R, Nagler E, Van Biesen W. Urinary and serum biomarkers for the diagnosis of acute kidney injury: An in-depth review of the literature. Nephrol Dial Transplant 2013; 28: 254-273.
36. Padberg JS, Wiesinger A, di Marco GS, Reuter S, Grabner A, Kentrup D, et al. Damage of the endothelial glycocalyx in chronic kidney disease. Atherosclerosis 2014; 234: 335-343.
37. Alvelos M, Pimentel R, Pinho E, Gomes A, Lourenco P, Teles MJ, et al. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Clin J Am Soc Nephrol 2011; 6: 476-481.
38. McCullough PA, Shaw AD, Haase M, Bouchard J, Waikar SS, Siew ED, et al. Diagnosis of acute kidney injury using functional and injury biomarkers: Workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013; 182: 13-29.
39. Dupont M, Shrestha K, Singh D, Awad A, Kovach C, Scarcipino M, et al. Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure. Eur J Heart Fail 2012; 14: 597-604.
40. Scrutinio D, Ammirati E, Guida P, Passantino A, Raimondo R, Guida V, et al. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure: Derivation and validation of the ADHF/NT-proBNP risk score. Int J Cardiol 2013; 168: 2120-2126.
41. Takishima I, Nakamura T, Hirano M, Kitta Y, Kobayashi T, Fujioka D, et al. Predictive value of serial assessment of endothelial function in chronic heart failure. Int J Cardiol 2012; 158: 417-422.
42. Rassaf T, Feelisch M, Kelm M. Circulating NO pool: Assessment of nitrite and nitroso species in blood and tissues. Free Radic Biol Med 2004; 36: 413-422.
43. Kleinbongard P, Dejam A, Lauer T, Jax T, Kerber S, Gharini P, et al. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 2006; 40: 295-302.